Ipratropium Bromide and Albuterol Sulfate (Teva Pharmaceuticals USA Inc)
Welcome to the PulseAid listing for the Ipratropium Bromide and Albuterol Sulfate drug offered from Teva Pharmaceuticals USA Inc. This Anticholinergic [EPC],Cholinergic Antagonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA Inc |
NON-PROPRIETARY NAME: | Ipratropium Bromide and Albuterol Sulfate |
SUBSTANCE NAME: | IPRATROPIUM BROMIDE; ALBUTEROL SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
ROUTE: | RESPIRATORY (INHALATION) |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2008-01-02 |
END MARKETING DATE: | 0000-00-00 |
Ipratropium Bromide and Albuterol Sulfate HUMAN PRESCRIPTION DRUG Details:
Item Description | Ipratropium Bromide and Albuterol Sulfate from Teva Pharmaceuticals USA Inc |
LABELER NAME: | Teva Pharmaceuticals USA Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | .5; 2.5(mg/3mL; mg/3mL) |
START MARKETING DATE: | 2008-01-02 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0093-6723_ed5da0f4-9b57-44dd-b0cb-ba7453066eb2 |
PRODUCT NDC: | 0093-6723 |
APPLICATION NUMBER: | ANDA076724 |
Other IPRATROPIUM BROMIDE; ALBUTEROL SULFATE Pharmaceutical Manufacturers / Labelers: